Institution profile

東京キャンサークリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 03C2606025 +4

Location

Prefecture
Tokyo
Address
千代田区飯田橋1丁目3-2 曙杉館ビル9F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 令和再生医療委員会
  • アトラス特定認定再生医療委員会
  • 個別化医療における認定再生医療等委員会

Public score

57.3/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 257of 1736

Registered technologies
5
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 57.3
Public score →100

Registered technologies (5)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪組織由来間葉系幹細胞による慢性疼痛の緩和Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪組織由来間葉系幹細胞による動脈硬化性疾患の予防と治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪組織由来間葉系幹細胞による慢性疼痛の緩和Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪組織由来間葉系幹細胞による動脈硬化性疾患の予防と治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
NK細胞を利用したがん免疫細胞療法NK and immune cellsClass III
NK/NKT/γδT細胞を利用したがん免疫細胞療法NK and immune cellsClass III
樹状細胞を利用したがん免疫細胞療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • 令和再生医療委員会
  • アトラス特定認定再生医療委員会
  • 個別化医療における認定再生医療等委員会

Public document number

  • 03C2606025
  • 03C2606033
  • 03C2512009
  • 03C2512010
  • 03C2512011
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪組織由来間葉系幹細胞による慢性疼痛の緩和Class II令和再生医療委員会03C2606025
自己脂肪組織由来間葉系幹細胞による動脈硬化性疾患の予防と治療Class IIアトラス特定認定再生医療委員会03C2606033
NK細胞を利用したがん免疫細胞療法Class III個別化医療における認定再生医療等委員会03C2512009
NK/NKT/γδT細胞を利用したがん免疫細胞療法Class III個別化医療における認定再生医療等委員会03C2512010
樹状細胞を利用したがん免疫細胞療法Class III個別化医療における認定再生医療等委員会03C2512011

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor